During the COVID-19 pandemic, there will be more of a reliance on expert guidance and less on evidence-based medicine when determining treatment protocols. During the COVID-19 pandemic, there will be more of a reliance on expert guidance and less on evidence-based medicine when determining treatment protocols.
Epidemiologic, clinical, microbiologic and antimicrobial resistance (AMR) data on nosocomial superinfections during the coronavirus disease 2019 (COVID-19) pandemic is needed to inform stewardship.
The study will enroll 400 patients with symptomatic coronavirus disease 201.
The phase 2b trial is expected to include roughly 2000 participants with confirmed SARS-CoV-2 who are experiencing fever, cough, and/or shortness of breath.
The impact of four widely adopted social distancing policies reduced the daily growth rate of COVID-19 acrossSS. counties.
The overall infection fatality rate (IFR) among symptomatic COVID-19 cases (IFR-S) in the United States is estimated at 1.3%.
Smokers have an increased likelihood of COVID-19 disease progression.
Researchers sought to identify disparities in risk to prevent, identify, and treat COVID-19-related severe illness and limit diverging outcomes for vulnerable subgroups.
Nearly half of cancer research has been stopped due to the COVID-19 pandemic.
The pandemic, and lifted restrictions in telehealth delivery, are hastening the adoption teledermatology in underserved patient populations.